Description of Patients Undergoing Mohs Surgery in Spain: Initial Report on Data From the Spanish Registry of Mohs Surgery (REGESMOHS)

Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma

“…Most of the MMS series for NMSC show that 90-95% of the tumors treated with this procedure are BCC, whereas 5-10% are SCC. 1,2,5,18 These data are consistent with our study. We found some differences in the patient characteristics of both groups, which are intrinsic to the epidemiology of the type of tumor: patients with SCC are older than patients with BCC (mean age of debut 70 years vs. 63 years); SCC is more frequent in male than in female patients; and SCC is more frequent in immunosuppressed patients.…”

“…Most of the MMS series for NMSC show that 90–95% of the tumors treated with this procedure are BCC, whereas 5–10% are SCC . These data are consistent with our study.…”

“…NMSC encompasses basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), and other rarer malignancies such as atypical fibroxanthoma, Merkel cell carcinoma, porocarcinoma, and microcystic adnexal carcinoma. BCC is the tumor most frequently treated with MMS, and SCC is the second most common type of tumor treated with this technique …”

“…BCC is the tumor most frequently treated with MMS, and SCC is the second most common type of tumor treated with this technique. 1,2 There are many studies that analyze MMS considering different factors, such as patient age, 3 anatomic location, [4][5][6][7] histologic type of tumor, [8][9][10] delay in treatment implementation, 11 and gender. 12 However, there are few studies comparing BCC MMS and SCC MMS.…”

Optical coherence tomography for margin definition of basal cell carcinoma before micrographic surgery—recommendations regarding the marking and scanning technique

“…A study made by a Spanish group specialized in MMS revealed that BCC was the most common type of skin cancer treated with MMS, consisting of almost 90% of all lesions. 7 Although MMS is efficient and responsible for the highest cure rate of skin cancers 1 and is the preferred therapeutic management for BCCs at high risk for recurrence, 8,9 MMS requires high knowledge skills of practitioners (by combining surgery with histopathology) as well as supporting histotechnicians to be able to perform this procedure, which may face some obstacles as financial and resource-related implications. 3 Besides, MMS is not free of complications and patient's clinical condition may be a contraindication to the realization of this technique.…”